Form 4: ClearPoint Neuro Director Acquires Shares as Compensation

Director Pascal E. R. Girin acquired 406 shares of ClearPoint Neuro stock as compensation for director fees.

Summary

• Pascal E. R. Girin, a director at ClearPoint Neuro, acquired 406 shares of common stock on January 2, 2025.
• The shares were issued as payment for director fees under the company's Non-Employee Director Compensation Plan.
• The shares were valued at $15.38 each, which was the closing price of ClearPoint Neuro's common stock on December 31, 2024.
• Following the transaction, Girin's total holdings increased to 74,493 shares.

Sentiment

Score: 7

Explanation: The transaction is a routine compensation event and does not indicate any significant positive or negative sentiment. The director receiving stock is a positive sign of alignment with shareholders.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of stock as compensation aligns director interests with shareholder interests.

Industry Context

This is a standard transaction for a director receiving compensation in the form of company stock, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Many publicly traded companies use stock-based compensation for directors to align their interests with shareholders.
• The practice of using the closing price on a specific date to value the shares is a standard method for such transactions.
• This type of transaction is common and does not indicate any unusual activity compared to other companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

ClearPoint Neuro, CLPT, insider trading, director compensation, stock acquisition, Form 4, Pascal Girin